PCV-7Pneumococcal Conjugate Vaccine
References in periodicals archive ?
For the present study, we selected nasopharyngeal samples of the group of children that received 3 vaccinations with PCV-7 (n = 336) and of the group of children that received no vaccinations with PCV-7 (controls) (n = 331).
We used univariate and multivariate linear regression models (function Im and analysis of variance in software package R) to study the effect of vaccination with PCV-7 on microbiota profiles.
Similar to the main trial (15), in this subset of children, baseline characteristics were not different between PCV-7 vaccinees and controls (Table).
This paper describes changes in the incidence and serotype distribution of IPD in BC in the seven years following implementation of the childhood PCV-7 immunization program in 2003 and under a reduced dose schedule.
Since the introduction of the PCV-7 program in 2003, rates among children under five have fallen by 78% (from 54.
Since implementation of the PCV-7 program, there has been a significant (p<0.
In 2010 a new pneumococcal conjugate vaccine (Prevnar-13[R]) has been licensed to replace PCV-7, adding additional serotype protection against pneumococcal disease in children and the community.
Incidence of pneumococcal conjugate vaccine (PCV-7) serotypes in the United States during the era of widespread PCV-7 vaccination, 1998-2004.
ayda PHID-CV veya PCV-7 uygulanmis ve son dozdan sonra antikor titresine ELISA ile bakilmis, antikor fonksiyonu OPA ile olculmustur.
Bir calismada PHID-CVninde PCV-7 gibi 2+1 uygulamasina uygun olup olmadigi immunojenite acisindan degerlendirilmistir.
All 4 of our patients had completed the PCV-7 series before becoming ill.
8 Race Black White Sex M M Completed PCV-7 series Yes Yes Co-illnesses Asthma None Clinical signs Date 2007 Nov 2007 Nov Temperature, [degrees]C 37.